Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study

Boris MichelMiriam NavarroMichael PritschJeremy Douglas Du PlessisJonathan P. ShockEva‐Maria Schwienhorst-StichJanina ZirkelHanna SchraderClaudia Saavedra IralaGonzalo Rubilar2026-03-222026-03-22202210.1136/bmjopen-2021-058572https://doi.org/10.1136/bmjopen-2021-058572https://andeanlibrary.org/handle/123456789/56016Citaciones: 2Social determinants of health, the unavailability of treatment and a wonder drug image might contribute to the phenomenon of vet-IVM.enMedicinePandemicFocus groupDiseaseIvermectinChagas diseasePublic healthBiostatisticsQualitative researchEnvironmental healthUnderstanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods studyarticle